Cite
HARVARD Citation
Gibbs, J. et al. (2017). Evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment. Journal of clinical pharmacology. pp. 513-523. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gibbs, J. et al. (2017). Evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment. Journal of clinical pharmacology. pp. 513-523. [Online].